Organon & Co (OGN) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - GENERAL

Exchange: NYSE

Key Metrics

• Price: $7.24
• Market Cap: $1.95B
• P/E Ratio: 10.43
• EPS: $0.72
• Dividend Yield: 0.04%
• 52-Week High: $15.93
• 52-Week Low: $6.15

Market Sentiment

Organon & Co currently has a Bullish sentiment score of 0.29.

About Organon & Co

Organon & Co. is a Jersey City-based global pharmaceutical company dedicated to advancing women's health through a robust portfolio that includes products in reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. With a strong focus on addressing unmet health needs, Organon leverages its deep industry expertise to deliver innovative solutions to global markets. Positioned at the forefront of the increasing demand for women's health interventions, Organo...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Organon & Co and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

What is OGN's current dividend yield?

Organon & Co (OGN) has a current dividend yield of 0.04%.

Does OGN pay dividends?

Yes, Organon & Co pays dividends with a current yield of 0.04%.

What is OGN's P/E ratio?

Organon & Co has a price-to-earnings (P/E) ratio of 10.43.

What is OGN's market cap?

Organon & Co (OGN) has a market capitalization of $1.95B with a current stock price of $7.24.